Secondary mania associated with the use of felbamate. 1995

R R Hill, and S J Stagno, and G E Tesar
Department of Psychiatry and Psychology, Cleveland Clinic Foundation, Ohio 44195 USA.

UI MeSH Term Description Entries
D008297 Male Males
D011409 Propylene Glycols Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations. Propanediols,Glycols, Propylene
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078328 Felbamate A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY. (3-Carbamoyloxy-2-phenyl-propyl) carbamate,2-Phenyl-1,3-propanediol dicarbamate,ADD-03055,Felbamyl,Felbatol,Taloxa,W-554,2 Phenyl 1,3 propanediol dicarbamate,ADD 03055,ADD03055,W 554,W554
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R R Hill, and S J Stagno, and G E Tesar
June 1981, The American journal of psychiatry,
R R Hill, and S J Stagno, and G E Tesar
May 1985, Clinical cardiology,
R R Hill, and S J Stagno, and G E Tesar
January 1986, Clinical cardiology,
R R Hill, and S J Stagno, and G E Tesar
November 1984, Clinical cardiology,
R R Hill, and S J Stagno, and G E Tesar
October 2015, Journal of clinical psychopharmacology,
R R Hill, and S J Stagno, and G E Tesar
January 1996, The Journal of clinical psychiatry,
R R Hill, and S J Stagno, and G E Tesar
June 1982, Biological psychiatry,
R R Hill, and S J Stagno, and G E Tesar
January 1981, Acta psychiatrica Belgica,
R R Hill, and S J Stagno, and G E Tesar
August 1995, Journal of clinical psychopharmacology,
R R Hill, and S J Stagno, and G E Tesar
May 1963, The American journal of psychiatry,
Copied contents to your clipboard!